Answers are grounded in this paper and cite their sources.
This study is the first to characterise the plasma exLR profile in PDAC and to report an exLR signature for the detection of pancreatic cancer. This signature may improve the prognosis of patients who would have otherwise missed the curative treatment window.
No takes yet. Share an insight, caveat, or question.
Yu et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: